Cencora (MIL:1COR) Beta: N/A (As of Jun. 26, 2026)


MIL:1COR Cencora Inc MIL:1COR
55 GF Score
Price €229.90
GF Value €233.91
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Cencora's Beta is Not available.


Cencora  (MIL:1COR) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Cencora Beta Related Terms


Cencora Beta Historical Data

* Premium members only.

The historical data trend for Cencora's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Beta Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cencora Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MIL:1COR
55GF Score
Cencora Inc MIL:1COR
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Cencora (MIL:1COR) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be undervalued. The current stock price of €229.90 is trading 1.7% below its estimated GF Value™ of €233.91. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for MIL:1COR:

  • Beta: N/A
  • GF Value™: €233.91 vs. price of €229.90 (1.7% below fair value)
  • GF Score™: 55/100 with 1 warning sign

No single metric tells the full story. See the MIL:1COR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
55GF Score

Get the complete analysis for MIL:1COR

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€229.90
Price
€233.91
GF Value